Open access · CC-BY
via OpenAlex
Impact of SIRT1 gene expression on the development and treatment of the metabolic syndrome in oncological patients
Pediatric Endocrinology Diabetes and Metabolism · 2016 · ▲ 7 citations
Abstract
Sirtuins - products of gene SIRT expression have been divided into 7 classes, according to the amino acid composition and location of the cell. Those factors, called longevities proteins, are a group of histone deacetylases, depend on nicotinamide adenine dinucleotide (NAD). Particularly noteworthy is the protein sirtuin 1, which further deacetylates numerous transcription factors, receptors and enzymes. Through its action reduces the activity of glucocorticoid receptors in the body. Products of gene SIRT1 expression is responsible for apoptosis, differentiation, senescence(definition) cells, also affect the regulation of carbohydrate and lipid metabolism. Cardioprotective and hypotensive impact is also very important. SIRT1 reduces the accumulation of fat and decreases the risk of visceral obesity. Low gene expression of SIRT1 therefore predispose to the development of metabolic syndrome. Homeostasis sirtuin 1 disorders can also be observed in certain neoplastic diseases, primarily hormone-dependent breast, ovarian and prostate cancer, as well as it can cause leukemias and lymphomas. Components, activating expression of gen SIRT1 or a molecule with biological properties sirtuin 1, may have promising impact for treatment of diabetes mellitus type 2, obesity, hypertension, dyslipidemia. Analyzing, the pleiotropic effect of sirtuin 1 and numerous metabolic pathways, appear to be particularly beneficial effect of supplementation molecules increasing the level of expression gene SIRT1, in treatment of acute lymphoblastic leukemia with using high-dosing glicocorticosteroid therapy. Which would reduce the number of early and late complications of oncological treatment and increase patient survival. Compound requires further study.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.18544/pedm-22.02.0052
- Canonical
- link ↗
- Fetched
- 2026-10-23 MST
Cite this
APA
Wawryka, J., & Barg, E. (2016). Impact of SIRT1 gene expression on the development and treatment of the metabolic syndrome in oncological patients. <em>Pediatric Endocrinology Diabetes and Metabolism</em>. https://doi.org/10.18544/pedm-22.02.0052
Vancouver
Wawryka J, Barg E. Impact of SIRT1 gene expression on the development and treatment of the metabolic syndrome in oncological patients. Pediatric Endocrinology Diabetes and Metabolism. 2016. doi:10.18544/pedm-22.02.0052.
BibTeX
@article{joanna2016Impact,
title = {Impact of SIRT1 gene expression on the development and treatment of the metabolic syndrome in oncological patients},
author = {Joanna Wawryka and Ewa Barg},
journal = {Pediatric Endocrinology Diabetes and Metabolism},
year = {2016},
doi = {10.18544/pedm-22.02.0052},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Pharmacology 2020
Open access · CC-BY
SIRT1 Activation by Natural Phytochemicals: An Overview
The FASEB Journal 2024
Open access · OA
Exploring nicotinamide adenine dinucleotide precursors across biosynthesis pathways: Unraveling their role in the ovary
Journal of Diabetes Research 2014
Open access · CC-BY
Renal Protective Effect of Sirtuin 1
Kidney Diseases 2015
Open access · OA
SIRT1 and Kidney Function
Cell Reports Medicine 2022
Open access · CC-BY
Time-restricted eating with or without low-carbohydrate diet reduces visceral fat and improves metabolic syndrome: A randomized trial
Journal of the American Heart Association 2021
Open access · CC-BY